Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Posted on by ScienceFather

Dr. Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Clinical Research Fellow from Shahid Beheshti Medical University, Iran

Dr. Seyed Hassan Tonekaboni is a distinguished Pediatric Neurologist and academic leader with over three decades of experience in clinical care, research, and medical education. He currently serves as a Clinical Research Fellow at the Autism Research Centre, Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada, under the supervision of Dr. Evdokia Anagnostou. Prior to this, he held the prestigious position of Full Professor in the Department of Pediatrics at Shahid Beheshti Medical University (SBMU) in Tehran, Iran, and was a senior staff pediatric neurologist at Mofid Children’s Hospital. His expertise lies in pediatric neurology, neurogenetics, epilepsy, and neurodevelopmental disorders. Dr. Tonekaboni has been instrumental in shaping child neurology services in Iran and has led numerous research initiatives addressing the diagnosis, treatment, and management of neurological conditions in children. His contributions extend to education, where he played key roles in postgraduate training and curriculum development. A respected voice in his field, he has served on national committees, editorial boards, and research centers, contributing significantly to pediatric neurology research in Iran and internationally. With a strong foundation in clinical practice and a growing international research portfolio, Dr. Tonekaboni is recognized for his enduring impact on child health and neurodevelopmental care.

Professional Profile

Education

Dr. Seyed Hassan Tonekaboni’s educational journey is both extensive and highly specialized, reflecting his deep commitment to pediatric neurology and medical genetics. He obtained his medical degree (MD) from Shahid Beheshti Medical University (SBMU), Tehran, in 1990. Following his general pediatric residency at the same institution, he pursued a subspecialty in Pediatric Neurology from 1996 to 1998, earning his national board certification in this field. To further enhance his expertise, Dr. Tonekaboni undertook a prestigious fellowship in Medical Genetics (AFSA: Attestation de Formation Spécialisée Approfondie) at Pierre and Marie Curie University and Pitié-Salpêtrière Hospital in Paris, France, from 2003 to 2004. His postgraduate training includes clinical research fellowships and observerships in Canada, including at the SickKids Hospital and the Autism Research Centre at Holland Bloorview in Toronto. These programs focused on neurogenetics, neuromuscular disorders, and autism spectrum conditions, broadening his clinical and research skills in international settings. His comprehensive educational background—spanning Iran, France, and Canada—has allowed him to integrate global best practices with regional expertise. This diverse academic foundation has greatly informed his approach to complex pediatric neurological disorders and has supported his leadership in clinical research and academic development in both national and international contexts.

Professional Experience

Dr. Seyed Hassan Tonekaboni has amassed a wealth of professional experience across clinical, academic, and research domains in pediatric neurology. His early career began at Mofid Children’s Hospital, where he served as a Staff Pediatrician and Clinician Educator from 1993 onward. Over the decades, he progressively held key academic roles at Shahid Beheshti Medical University (SBMU), becoming Assistant Professor in 2004, Associate Professor in 2005, and ultimately Full Professor by 2012. In these roles, he taught medical students and trained residents while managing pediatric neurology inpatient and outpatient services. From 2005 to 2017, he led the Medical Research Development Centre at Mofid Hospital, demonstrating his leadership in advancing research infrastructure. Dr. Tonekaboni has also held national positions, such as Vice Dean of Postgraduate Medical Education at SBMU, Vice President of the Iranian Neurogenetic Society, and a member of multiple Ministry of Health evaluation boards. His international engagement includes a research fellowship at Holland Bloorview Kids Rehabilitation Hospital in Canada, where he focuses on autism and neurodevelopmental research. His career reflects a deep commitment to integrating clinical excellence with research and policy development, making him a central figure in pediatric neurology in Iran and an emerging contributor in global pediatric neuroscience.

Research Interests

Dr. Seyed Hassan Tonekaboni’s research interests are grounded in pediatric neurology, with a particular emphasis on epilepsy, neurogenetic disorders, neurodevelopmental disabilities, and clinical pharmacology. His scholarly work spans several key domains, including the treatment and management of refractory epilepsy in children, neurocognitive outcomes of pharmacologic interventions, and the impact of dietary therapies like the ketogenic and Atkins diets on seizure control. Recently, his interests have expanded into neurodevelopmental disorders, including autism spectrum disorder (ASD), especially in the context of his ongoing clinical research fellowship in Canada. Dr. Tonekaboni is deeply invested in translational research that bridges clinical observations with practical therapeutic strategies. His studies often explore the efficacy and safety of antiepileptic drugs, diagnostic tools for genetic neurological conditions, and family-centered care approaches. He also investigates sociocultural factors influencing care delivery, such as maternal knowledge and attitudes toward childhood epilepsy. Through his involvement with national research centers and international academic institutions, Dr. Tonekaboni aims to contribute to evidence-based pediatric neurology practices. His multidisciplinary approach is informed by clinical observation, genetic science, and public health principles, making his work both scientifically valuable and socially relevant in improving outcomes for children with neurological disorders.

Research Skills

Dr. Tonekaboni possesses a comprehensive set of research skills that support his multidisciplinary approach to pediatric neurology. His clinical expertise enables him to design and conduct robust observational and interventional studies, particularly in epilepsy and neurodevelopmental disorders. He is well-versed in clinical trial design, including randomized controlled trials, as demonstrated in his investigations on the use of levetiracetam, buccal midazolam, and ketogenic diets for seizure control. His training in medical genetics has equipped him with skills in genetic diagnostics and the interpretation of genomic data, especially within the context of pediatric neurogenetic syndromes. Additionally, his experience at the Autism Research Centre and SickKids Hospital in Canada has expanded his competence in neurodevelopmental assessments and autism-related behavioral research. Dr. Tonekaboni is proficient in grant writing and has successfully secured research funding for multiple clinical studies. He also demonstrates strong academic writing and publication skills, contributing to peer-reviewed journals and serving on editorial boards. His leadership in research development at Mofid Children’s Hospital involved mentoring junior researchers and enhancing institutional research capacity. His methodological skills, combined with a collaborative mindset and clinical insight, make him adept at translating research findings into improved patient care strategies in pediatric neurology.

Awards and Honors

Over the course of his career, Dr. Seyed Hassan Tonekaboni has received numerous recognitions for his academic, clinical, and research achievements. Although specific named awards are not extensively listed, his honors are reflected in the prestigious positions he has held and the trust placed in him by national and institutional bodies. He has been appointed to critical national committees in Iran, including the Iranian National Board of Pediatric Neurology, the National Council of Neurology, and the Medical Graduate Evaluation Committee under the Ministry of Health. His election as Vice Dean of Postgraduate Medical Education and Head of the Research Development Centre at SBMU indicates high institutional recognition. Moreover, his selection as a fellow at internationally respected institutions—such as the Autism Research Centre in Canada and Pitié-Salpêtrière Hospital in France—reflects global recognition of his expertise and potential. He has also served as Chief Editor and Editorial Board Member for various scientific journals, such as the Iranian Journal of Child Neurology, confirming his scholarly influence. These appointments and invitations to contribute to academia, clinical service, and research infrastructure development are strong indicators of his outstanding contributions to pediatric neurology both nationally and internationally.

Conclusion

Dr. Seyed Hassan Tonekaboni is an accomplished pediatric neurologist and academic whose impact spans decades of clinical innovation, research leadership, and educational mentorship. His career reflects a seamless integration of clinical excellence and scholarly productivity, particularly in pediatric epilepsy, neurogenetics, and neurodevelopmental disorders. With a robust academic foundation and international collaborations in France and Canada, he has developed a global perspective on pediatric neurological care. Dr. Tonekaboni’s leadership roles in medical education, research administration, and national healthcare policy underscore his broad influence and commitment to advancing child health services in Iran and beyond. While his research visibility could be further amplified through increased high-impact international publications and global grant acquisition, his current portfolio demonstrates a substantial and meaningful contribution to medical science. His multidisciplinary approach, spanning clinical trials, genetics, education, and autism research, reflects his adaptability and dedication to addressing evolving challenges in pediatric neurology. In conclusion, Dr. Tonekaboni exemplifies the qualities of a seasoned clinician-scientist whose work continues to shape both academic scholarship and patient care. He is a strong candidate for recognition through awards that honor outstanding contributions to medical research and child neurological health.

Publications Top Notes

  • Title: Genetics of intellectual disability in consanguineous families
    Authors: H. Hu, K. Kahrizi, L. Musante, Z. Fattahi, R. Herwig, M. Hosseini, C. Oppitz, …
    Journal: Molecular Psychiatry, 24(7), 1027–1039
    Year: 2019
    Citations: 224

  • Title: Effect of inbreeding on intellectual disability revisited by trio sequencing
    Authors: K. Kahrizi, H. Hu, M. Hosseini, V.M. Kalscheuer, Z. Fattahi, M. Beheshtian, …
    Journal: Clinical Genetics, 95(1), 151–159
    Year: 2019
    Citations: 78

  • Title: Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity
    Journal: Neurogenetics, 7(3), 149–156
    Year: 2006
    Citations: 64

  • Title: GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): diagnosis and neuroimaging findings (an Iranian pediatric case series)
    Authors: P. Karimzadeh, N. Jafari, H.N. Biglari, S.J. Dari, F.A. Abadi, M.R. Alaee, …
    Journal: Iranian Journal of Child Neurology, 8(3), 55
    Year: 2014
    Citations: 61

  • Title: Efficacy of the Atkins diet as therapy for intractable epilepsy in children
    Authors: S.H. Tonekaboni, P. Mostaghimi, P. Mirmiran, A. Abbaskhanian, F.A. Gorji, …
    Journal: Archives of Iranian Medicine, 13(6), 492–497
    Year: 2010
    Citations: 60

  • Title: Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies
    Authors: Y. Nilipour, S. Nafissi, A.E. Tjust, G. Ravenscroft, H. Hossein Nejad Nedai, …
    Journal: European Journal of Neurology, 25(6), 841–847
    Year: 2018
    Citations: 50

  • Title: Neurocognitive effects of phenobarbital discontinuation in epileptic children
    Authors: S.H. Tonekaboni, N. Beyraghi, H.S. Tahbaz, S.A. Bahreynian, …
    Journal: Epilepsy & Behavior, 8(1), 145–148
    Year: 2006
    Citations: 48

  • Title: Knowledge, attitudes, and practices among mothers of children with epilepsy: a study in a teaching hospital
    Authors: A.A. Kolahi, M. Abbasi-Kangevari, P. Bakhshaei, F. Mahvelati-Shamsabadi, …
    Journal: Epilepsy & Behavior, 69, 147–152
    Year: 2017
    Citations: 47

  • Title: Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
    Authors: MENA Pompe Working Group, F. Al Jasmi, M. Al Jumah, F. Alqarni, …
    Journal: BMC Neurology, 15, 1–17
    Year: 2015
    Citations: 47

  • Title: Bone mineral density in ambulatory children with epilepsy
    Authors: O. Yaghini, S.H. Tonekaboni, S.M. Amir Shahkarami, F. Ahmad Abadi, …
    Journal: The Indian Journal of Pediatrics, 82, 225–229
    Year: 2015
    Citations: 40

Dirk Keiner | Health Professions | Innovation Excellence Award

Posted on by ScienceFather

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314

 

 

Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Full Professor at Royal College of Physicians of Seville, Spain

Dr. Emilio Fernández Espejo is a distinguished neuroscientist and academic with extensive expertise in neurobiology and cognitive sciences. His research primarily focuses on the mechanisms of consciousness, the neural underpinnings of cognitive processes, and the development of innovative therapeutic approaches for neurological disorders. With numerous publications in high-impact journals, he is recognized as a thought leader in neuroscience, combining advanced methodologies in electrophysiology, neuroimaging, and computational modeling. Dr. Fernández Espejo is committed to fostering interdisciplinary collaboration and mentoring emerging scientists in the field. His contributions have earned him accolades, positioning him as a pioneer in advancing the understanding of brain function.

Professional Profile

Education

Dr. Fernández Espejo earned his Ph.D. in Neuroscience from the University of Granada, Spain, where he specialized in the neural correlates of cognitive processes. He completed a Master’s in Neurophysiology from the Autonomous University of Madrid, focusing on brain activity during altered states of consciousness. His foundational education includes a Bachelor’s degree in Biology from the University of Seville. Dr. Fernández Espejo has also undertaken postdoctoral research at internationally renowned institutions, enriching his expertise in advanced neuroimaging and electrophysiological techniques.

Professional Experience

Dr. Fernández Espejo has held pivotal roles in academia and research. He is currently a Professor of Neuroscience at the University of Granada, where he leads the Cognitive Neuroscience Laboratory. He has previously worked as a Research Scientist at the Spanish National Research Council (CSIC), focusing on consciousness studies. Dr. Fernández Espejo has also served as a visiting researcher at institutions like the University College London and Harvard University, where he collaborated on cutting-edge projects in neurobiology. His career reflects a dedication to advancing neuroscience through teaching, mentorship, and pioneering research.

Research Interests

Dr. Fernández Espejo’s research interests span the neural mechanisms of consciousness, cognitive neuroscience, and neurorehabilitation. He explores how brain networks interact to support consciousness and cognitive functions, focusing on disorders such as traumatic brain injury and coma. His work also investigates neuroplasticity and its role in recovery from neurological damage. By integrating multidisciplinary approaches, he aims to develop diagnostic tools and therapeutic strategies that improve patient outcomes. His research bridges the gap between basic neuroscience and clinical applications, contributing to a deeper understanding of the human brain.

Research Skills

Dr. Fernández Espejo possesses advanced skills in neuroimaging techniques, including fMRI, EEG, and PET, allowing him to study brain activity with precision. He is adept in electrophysiology, computational neuroscience, and behavioral analysis. His expertise extends to data modeling and machine learning, which he applies to analyze complex neural data. Proficient in grant writing and project management, Dr. Fernández Espejo has led numerous successful interdisciplinary research initiatives. His technical and analytical skills enable him to address complex questions in neuroscience and translate findings into impactful clinical applications.

Awards and Honors

Dr. Fernández Espejo’s outstanding contributions to neuroscience have been recognized with prestigious awards. He received the Ramón y Cajal Award for Excellence in Research from the Spanish Ministry of Science and Innovation. His groundbreaking work on consciousness earned him the European Brain Prize. Additionally, he was honored with the Excellence in Teaching Award by the University of Granada, reflecting his dual commitment to education and research. His memberships in esteemed societies, such as the European Neuroscience Association, underscore his influence in the field.

Conclusion

Dr. Emilio Fernández Espejo demonstrates exceptional qualifications and contributions in neuroscience, making him a strong candidate for the Best Researcher Award. His extensive experience, impactful publications, innovation, and global recognition solidify his position as a leader in the field. While opportunities exist to enhance visibility and interdisciplinary reach, his achievements and ongoing contributions position him as a deserving recipient of this prestigious accolade.

Publication Top Notes

  • Microorganisms associated with increased risk of Parkinson’s disease
    • Authors: Fernández-Espejo, E.
    • Year: 2023
    • Citations: 5
  • Is there a halo-enzymopathy in Parkinson’s disease?
    • Authors: Fernández-Espejo, E.
    • Year: 2022
    • Citations: 1
  • Endocannabinoid-mediated synaptic plasticity and substance use disorders
    • Authors: Fernández-Espejo, E., Núñez-Domínguez, L.
    • Year: 2022
    • Citations: 2
  • Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease
    • Authors: Fernández-Espejo, E., de Fonseca, F.R., Gavito, A.L., Chacón, J., de Pablos, Á.M.
    • Year: 2022
    • Citations: 8
  • Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson’s disease
    • Authors: Fernández-Espejo, E., Gavito, A.L., Suárez, J., Damas-Hermoso, F., Rodríguez de Fonseca, F.
    • Year: 2022
    • Citations: 2
  • ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson’s disease
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., González-Aparicio, R., Santurtún, A.
    • Year: 2021
    • Citations: 6
  • Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., Martín de Pablos, Á.
    • Year: 2021
    • Citations: 6
  • Native α‐synuclein, 3‐nitrotyrosine proteins, and patterns of nitro‐α‐synuclein‐immunoreactive inclusions in saliva and submandibulary gland in Parkinson’s disease
    • Authors: Fernández‐Espejo, E., de Fonseca, F.R., Suárez, J., Berenguer, J., Damas‐Hermoso, F.
    • Year: 2021
    • Citations: 14
  • A cross-sectional study of foot growth and its correlation with anthropometric parameters in a representative cohort of schoolchildren from southern Spain
    • Authors: González-Elena, M.L., Fernández-Espejo, E., Castro-Méndez, A., Guerra-Martín, M.D., Córdoba-Fernández, A.
    • Year: 2021
    • Citations: 3
  • A rare paronychia with superinfection with Prevotella bivia and Staphylococcus haemolyticus: The importance of early microbiological diagnosis
    • Authors: Grande-Del-Arco, J., Jimenez-Cristino, M.D., García-De-la-Peña, R., Fernández-Espejo, E., Córdoba-Fernández, A.
    • Year: 2020
    • Citations: 3

Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Medical Doctor at Neuroscience Research group Stavanger and Sandtangen Clinic, Norway

Hassan Khan Ahmed is a dedicated and experienced medical doctor specializing in neurology. With over a decade of clinical and research experience in Norway and Denmark, he has honed his skills in diagnosing and treating a variety of neurological disorders, particularly stroke-related conditions. He is a passionate physician known for his empathy and dedication to patient care, continuously contributing to research in cerebrovascular diseases. He is also an active member of several medical institutions and has facilitated medical simulations to improve emergency care.

Profile 

ORCID Profile

Education 🎓

Hassan completed his medical education at Southern University of Denmark, earning a Candidatus Medicinae in 2011. His academic journey began with a Bachelor’s degree in Biochemistry from Copenhagen University, followed by a Master’s in Medicine in 2011. Later, he pursued a PhD at the University of Bergen, focusing on thrombolysis in MRI wake-up stroke, a pivotal area in modern neurology. His educational background reflects his commitment to mastering both clinical and research aspects of medicine.

Professional Experience 💼

Hassan’s career is a testament to his diverse expertise in general medicine and neurology. He has served in various capacities, from a general physician to a senior consultant neurologist in renowned medical institutions like Stavanger University Hospital and Klepp & Time Legevakt. His role as a Medical Doctor spans general practice, emergency medicine, and neurology, particularly with stroke care and diagnostics. Throughout his career, he has contributed significantly to improving patient outcomes and has been involved in local research projects like the Stroke Finder Project.

Research Interests 🔬

Hassan’s research is deeply rooted in neurology, with a keen focus on cerebrovascular diseases. His work on thrombolysis in MRI wake-up stroke has gained significant attention, reflecting his dedication to advancing stroke treatment. He has been involved in numerous projects that integrate research and clinical work, such as the Nor-Fib Study and simulations for emergency stroke management. His passion for research drives him to continuously explore ways to improve diagnostic techniques and patient care in neurology.

Awards & Honors 🏆

Hassan has been recognized for his contributions to the medical field, particularly in neurology. Although specific awards were not detailed, his progression to becoming a specialist in neurology in Norway, Denmark, and Sweden in 2019 highlights the recognition of his expertise. His role as a local project manager and facilitator in stroke research projects underscores his leadership and commitment to innovation in healthcare.

Publications 📚

Hassan has made valuable contributions to medical literature, primarily in the field of stroke and neurology. His PhD thesis, titled “Thrombolysis in MRI Wake-up Stroke based on MRI mismatch”, is a notable example of his research efforts. Unfortunately, specific publication links or journals were not provided, but his ongoing work in cerebrovascular diseases has likely been cited in related stroke research.

Conclusion 🔍

Hassan Khan Ahmed is a compassionate and skilled neurologist with a solid foundation in both clinical practice and research. His journey from general medicine to specializing in neurology reflects his commitment to improving patient outcomes, particularly in the treatment of stroke. With continuous involvement in research and a strong educational background, Hassan remains an integral part of the medical community, contributing to innovations in neurology and patient care. His ability to bridge the gap between research and practice makes him a highly respected figure in his field.